Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19

被引:4
|
作者
Shakrawal, Jyoti [1 ]
Sharma, Vidhu [2 ]
Goyal, Amit [2 ]
Kumar, Deepak [3 ]
Meena, Seema [1 ]
Tiwari, Sarbesh [4 ]
Jain, Vidhi [5 ]
Elhence, Poonam [6 ]
Soni, Kapil [2 ]
Choudhury, Bikram [2 ]
Bhatnagar, Kavita [1 ]
Garg, Mahendra Kumar [3 ]
Misra, Sanjeev [7 ]
机构
[1] All India Inst Med Sci AIIMS, Dept Ophthalmol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[2] All India Inst Med Sci AIIMS, Dept Otorhinolaryngol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[3] All India Inst Med Sci AIIMS, Dept Gen Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[4] All India Inst Med Sci AIIMS, Dept Diagnost & Intervent Radiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[5] All India Inst Med Sci AIIMS, Dept Microbiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[6] All India Inst Med Sci AIIMS, Dept Pathol & Lab Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[7] All India Inst Med Sci AIIMS, Dept Surg Oncol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
关键词
COVID-19; Transcutaneous retrobulbar Amphotericin B; Rhino-orbital-cerebral-mucormycosis; MANAGEMENT;
D O I
10.1007/s10792-022-02591-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To assess the outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) for rhino-orbital-cerebral-mucormycosis (ROCM) post-COVID-19, as an adjuvant to standard systemic antifungal therapy. Methods In this prospective cohort study involving ROCM patients with clinical/radiological orbital involvement, 44 eyes with ROCM stage >= 3B received TRAMB for 7 consecutive days with liposomal Amphotericin-B (3.5 mg/ml) with a minimum clinical and radiological follow-up of 3 months. All patients received standard systemic antifungal therapy also as per institutional protocol. Data pertaining to demography, systemic status, clinical involvement, imaging, surgical/medical management were also recorded. Potential eyes for exenteration were excluded. Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author 12 Given name: [Mahendra Kumar ] Last name [Garg]. Also, kindly confirm the details in the metadata are correct.All author names are presented accurately. Details in the metadata are correct. Thank you. Results Forty-four eyes of 42 patients were included, out of which 30 had diabetes mellitus & 22 had received steroid/oxygen treatment during COVID-19 infection. Forty eyes showed improvement or stable disease on follow-up on radiology. Four eyes which showed progression of the disease in orbit were reaugmented with TRAMB. No patient required exenteration. Subconjunctival haemorrhage occurred in six eyes and temporary blurring of vision in four eyes after TRAMB which resolved spontaneously. Conclusion TRAMB, as an adjuvant to standard systemic antifungal therapy, is associated with a significant reduction or stabilisation of orbital involvement. TRAMB should be considered as an adjuvant therapy for ROCM to reduce disease progression as well as to preserve globe or sight. It has a promising role in preventing potential orbital exenterations.
引用
收藏
页码:1919 / 1926
页数:8
相关论文
共 50 条
  • [21] Retrobulbar Amphotericin B Injection in Curbing the Progression of COVID Associated Rhino-orbital Cerebral Mucormycosis: A Retrospective Case Series
    Pathak, Madhumallika
    Sahu, Vijaya
    Arora, Ripu Daman
    Shambharkar, Martina M.
    Naveen, Prithvi
    Pati, Saroj Kumar
    Nagarkar, Nitin M.
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 2) : 3352 - 3358
  • [22] Rhino-Orbital-Cerebral Mucormycosis in a Young Diabetic Patient with COVID-19 in Ethiopia: A Case Report
    Alemayehu, Fikremariam Melkeneh
    Abate, Hannibal Kassahun
    Soboka, Tariku Assefa
    Huluka, Dawit Kebede
    Worke, Alemayehu Bedane
    Abrie, Mahlet Tsegaye
    Dibaba, Dawit Kebebaw
    Asnake, Yilkal Birhanu
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2022, 15 : 251 - 257
  • [23] Estimation of the pattern of ocular manifestations, risk factors, and imaging of rhino-orbital-cerebral mucormycosis in COVID-19 patients
    Kaur, Rajwinder
    Budhiraja, Grace
    Bhumbla, Upasana
    Kaur, Manjot
    Sharma, Vandana
    Gupta, Priyanka
    Singla, Ritesh
    Goel, Akashdeep
    Gupta, Ekta
    Dahiya, Priyanka
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2025, 14 (01) : 259 - 267
  • [24] A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India
    Vasanthapuram, Varshitha Hemanth
    Gupta, Roshmi
    Adulkar, Namrata
    Nair, Akshay Gopinathan
    Bradoo, Renuka A.
    Hegde, Raghuraj
    Singh, Usha
    Tadepalli, Sameeksha
    Mukherjee, Bipasha
    Kamal, Saurabh
    Alam, Md Shahid
    Rao, Raksha
    Ananthakrishna, Sushma
    Backiavathy, Varsha
    Murthy, Ajay Krishna
    D'Cunha, Lynn
    Dudeja, Gagan
    Joji, Annie
    Kiran, Anjali
    Koka, Kirti
    Goswami Mukhopadhyay, Moupia
    Nisar, Sonam Poonam
    Rao, Priyanka R.
    Shinde, Chhaya A.
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2023, 42 (01): : 30 - 41
  • [25] Spike in Rhino-Orbital-Cerebral Mucormycosis Cases Presenting to a Tertiary Care Center During the COVID-19 Pandemic
    Fouad, Yousef A.
    Abdelaziz, Tougan Taha
    Askoura, Anas
    Saleh, Mohamed Ibrahim
    Mahmoud, Mohammad S.
    Ashour, Doaa Maamoun
    Ashour, Manar Maamoun
    FRONTIERS IN MEDICINE, 2021, 8
  • [26] Rhino-Orbital-Cerebral Mucormycosis in a Post-COVID-19 Patient from Peru
    Ponce-Rosas, Linda
    Gonzales-Zamora, Jose
    Diaz-Reyes, Nelson
    Alarco-Cadillo, Oliver
    Alave-Rosas, Jorge
    CASE REPORTS IN INFECTIOUS DISEASES, 2022, 2022
  • [27] Optimization of Oral Posaconazole Step Down Therapy in Management of Rhino-Orbital-Cerebral Mucormycosis (ROCM): Outcome of an Institutional Protocol
    Monoj Mukherjee
    Arvind Kumar Verma
    Titli Bandyopadhyay
    V. V. D. Prasanna Kumar
    S. Satish Reddy
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2023, 75 : 3077 - 3083
  • [28] Optimization of Oral Posaconazole Step Down Therapy in Management of Rhino-Orbital-Cerebral Mucormycosis (ROCM): Outcome of an Institutional Protocol
    Mukherjee, Monoj
    Verma, Arvind Kumar
    Bandyopadhyay, Titli
    Kumar, V. V. D. Prasanna
    Reddy, S. Satish
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2023, 75 (04) : 3077 - 3083
  • [29] Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis
    Murthy, Ramesh
    Bagchi, Aadhyaa
    Gote, Yogita
    Desai, Sanjay
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (01) : 302 - 305
  • [30] Study of rhino-orbital-cerebral mucormycosis and its correlates during COVID-19 pandemic in a tertiary eye care institute of central India
    Verma, Vidhya
    Sarkar, Deepayan
    Moharana, Bruttendu
    Singh, Priti
    Noyadu, Richa
    Sharma, Bhavana
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (12) : 3669 - 3676